Search research articles
Contact Us
Filters
Showing results (11-20 of 13) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 13 results.
European Journal of Medicinal Chemistry
|
September 26, 2025
(N)-Methanocarba-adenosines as monoamine transporter allosteric inhibitors: Extended N<sup>6</sup> groups for bitopic stabilization
Dilip K Tosh, Matteo Pavan, Laura B Kozell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 7, 2024
Pharmacologic Characterization of Substituted Nitazenes at <i>μ</i>, <i>κ</i>, and <i>Δ</i> Opioid Receptors Suggests High Potential for Toxicity
Laura B Kozell, Amy J Eshleman, Katherine M Wolfrum, et al.
ACS Pharmacology & Translational Science
|
January 15, 2026
Evaluation of the Relationship between Vesicular Monoamine Transporter 2 (VMAT2) Inhibition and Neurologic Adverse Events in Approved Drugs
Rebecca Racz, Laura B Kozell, Amy J Eshleman, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 13) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 13 results.
European Journal of Medicinal Chemistry
|
September 26, 2025
(N)-Methanocarba-adenosines as monoamine transporter allosteric inhibitors: Extended N<sup>6</sup> groups for bitopic stabilization
Dilip K Tosh, Matteo Pavan, Laura B Kozell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 7, 2024
Pharmacologic Characterization of Substituted Nitazenes at <i>μ</i>, <i>κ</i>, and <i>Δ</i> Opioid Receptors Suggests High Potential for Toxicity
Laura B Kozell, Amy J Eshleman, Katherine M Wolfrum, et al.
ACS Pharmacology & Translational Science
|
January 15, 2026
Evaluation of the Relationship between Vesicular Monoamine Transporter 2 (VMAT2) Inhibition and Neurologic Adverse Events in Approved Drugs
Rebecca Racz, Laura B Kozell, Amy J Eshleman, et al.
Page
of 2